bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/095257

GeNNet: An Integrated Platform for Unifying Scientific Workflow Management and Graph Databases for Transcriptome Data Analysis

L. Costa, R.·Gadelha, L.·Ribeiro-Alves, M.·Porto, F.
View original source ↗Export metadata ↓

Abstract

BackgroundThere are many steps in analyzing transcriptome data, from the acquisition of raw data to the selection of a subset of representative genes that explain a scientific hypothesis. The data produced may additionally be integrated with other biological databases, such as Protein-Protein Interactions and annotations. However, the results of these analyses remain fragmented, imposing difficulties, either for posterior inspection of results, or for meta-analysis by the incorporation of new related data. Integrating databases and tools into scientific workflows, orchestrating their execution, and managingthe resulting data and its respective metadata are challenging tasks. Running in-silico experiments to structure and compose the information as needed for analysis is a daunting task. Different programsmay need to be applied and different files are produced during the experiment cycle. In this context,the availability of a platform supporting experiment execution is paramount.\n\nResultsWe present GeNNet, an integrated transcriptome analysis platform that unifies scientific workflows with graph databases for selecting relevant genes according to the evaluated biological systems. GeNNet includes pre-loaded biological data, pre-processes raw microarray data and conducts a series of analyses including normalization, differential expression inference, clusterization and geneset enrichment analysis. To demonstrate the features of GeNNet, we performed case studies with data retrieved from GEO, particularly using a single-factor experiment. As a result, we obtained differentially expressed genes for which biological functions were analyzed. The results are integrated into GeNNet-DB, a database about genes, clusters, experiments and their properties and relationships.The resulting graph database is explored with queries that demonstrate the expressiveness of this data model for reasoning about gene regulatory networks.\n\nConclusionsGeNNet is the first platform to integrate the analytical process of transcriptome data with graph database. It provides a comprehensive set of tools that would otherwise be challenging for non-expert users to install and use. Developers as well can add new functionality to each component of GeNNet. The resulting data allows for testing previous hypotheses about an experiment as well as exploring new ones through the interactive graph database environment. It enables the analysis of different data on humans, rhesus, mice and rat coming from Affymetrix platforms.

Source connections

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L. Costa, R., Gadelha, L., Ribeiro-Alves, M., Porto, F.. 2016-12-18. GeNNet: An Integrated Platform for Unifying Scientific Workflow Management and Graph Databases for Transcriptome Data Analysis. https://doi.org/10.1101/095257

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Cellular composition and the interpretation of candidate RNA readouts of trogocytosis in colorectal cancer

Background: RNA measurements of genes associated with trogocytosis may reflect cellular composition rather than contact-dependent membrane acquisition. We evaluated an eight-gene candidate module in colorectal cancer (CRC) using expression- and lineage-matched random modules, independent compartment analysis and patient-level inference. A separate rare-transcript definition and cancer-model fitness screens provided complementary analyses. Results: In 62 GSE178341 patients, the module correlated with T-cell fraction ({rho}=0.767), but this association was typical of 10,000 matched modules (null median 0.766; one-sided empirical P=0.493; equal-tail two-sided P=0.985). A post hoc closest-10% matching sensitivity gave P=0.571. In 23 independent GSE132465 patients, the tumour-wide correlation was 0.735 (permutation P=0.00060) and the epithelial correlation was 0.376 (P=0.0892). The difference in absolute correlations was 0.359, with a 95% confidence interval of -0.041 to 0.759, leaving attenuation uncertain. Among 43,817 leukocytes, 16 CEACAM5-positive candidates arose from four patients; 15 had expression [≤]2 transcripts per million. Candidate counts were threshold-sensitive. No survival association was detected for the module in two cohorts. SCD fitness dependency reproduced across CRC organoids and cell lines, whereas adjusted SCD-VPS72 and exploratory ATF3-SMYD2 co-dependencies did not. Exploratory CH25H, ATF3 and FADS2 analyses yielded no Hallmark enrichment meeting the multiple-testing threshold. Conclusions: Matched-module calibration placed the strong association with T-cell abundance within the range expected for comparable immune-lineage genes. Independent compartment analysis was consistent with a contribution from cellular composition, although attenuation remained uncertain. These results identify the comparison conditions needed to interpret the tested RNA readouts. Linking them to membrane transfer requires event-resolved protein measurements.

bioinformatics↗
bioRxiv2026

NeuroWeave-3D: Uncertainty-Aware Evidence Completion for Brain Tumor Segmentation with Missing MRI Modalities

Multi-parametric MRI segmentation models are accurate when all prescribed sequences are available but can be brittle under missing or corrupted modalities. We propose NeuroWeave-3D, a 3D glioma segmentation framework that treats missing modalities as uncertain evidence rather than deterministic channels to reconstruct. The model combines spatial modality routing, probabilistic latent feature completion, complete-to-missing consistency, and voxel-level uncertainty estimation. A curriculum over all non-empty MRI modality subsets trains one network for arbitrary sequence availability. We define a BraTS-centered evaluation that reports complete-input accuracy, macro and worst-case missing-modality performance, corruption robustness, calibration, and failure detection.

bioinformatics↗
bioRxiv2026

Differential Gene Expression and Functional Enrichment Analysis of Breast Tumor and Normal Tissue RNA-seq Data: A Reanalysis of GEO Dataset GSE210787

Background: RNA sequencing (RNA-seq) allows a global assessment of expression differences between biological states. The present study reanalyzed publicly available RNA-seq data from human breast tumors and normal tissues to identify DEGs and to investigate functional enrichment. Methods: Twelve paired-end RNA-seq samples from the GEO series GSE210787 were analyzed, including six tumor and six normal samples. Reads were obtained using the SRA Toolkit, checked with FastQC and MultiQC, trimmed with fastp, aligned to the GRCh38.p14 reference with STAR, and quantified at the gene level with featureCounts. Differential expression analysis was performed using DESeq2 in the Galaxy environment. The project report details criteria of adjusted p-value < 0.05 and absolute log2 fold change [&ge;] 1. Gene Ontology enrichment was performed using g:Profiler and KEGG overrepresentation analysis was performed separately for the up- and down-regulated gene sets. Results: The project report contains a list of 120 differentially expressed genes (DEGs), including 69 upregulated and 51 downregulated genes in tumor tissue compared with normal tissue. One upregulated-gene GO Cellular Component term, cell periphery (GO:0071944), was observed with a P-value of approximately 0.017585 and 29 overlapping genes. The original report does not specify if this P-value is nominal or adjusted. No significant GO terms were found for the down-regulated gene set. After multiple testing corrections, no KEGG pathway was significant; the lowest adjusted p-value for the upregulated group was about 0.71393. Conclusion: The project identified differences in expression between tumor and normal samples, but no KEGG pathway reached the set FDR significance threshold. The final interpretation needs to check sample metadata, DESeq2 contrast, GO significance statistic, KEGG background universe and analytical parameters against the original results. Keywords: RNA-seq; breast tumor; differential expression; DESeq2; Gene Ontology; KEGG pathway; transcriptomics; cell periphery.

bioinformatics↗